title: Oral recurrent human herpes virus infection and bone marrow transplantation survival.
abstract: OBJECTIVE
  This study was conducted to compare the survival rates of bone marrow transplantation (BMT) patients who were affected with the survival rates of those who were not affected by oral recrudescent human herpes virus-1 infection (HHV-1) after transplantation.
  
  
  METHODS
  Fifty-two consecutive patients who underwent BMT were included in the study. The time of death after BMT was displayed, by means of the Kaplan-Meier method, for the following parameters: age and gender of the patient, donor gender, primary disease, stem cells, conditioning regimen, platelet number after day 100, acute and chronic graft-versus-host disease, oral recurrent HHV-1 infection post-BMT, oral lichenoid lesions of graft-versus-host disease, graft-versus-host disease at the salivary glands, parenteral nutrition, and oral mucositis. The data were initially analyzed by means of the log-rank test and then included in the Cox proportional hazards model.
  
  
  RESULTS
  The multivariate analysis demonstrated a significance of 5% for only the platelet numbers and oral recurrent HHV-1 infection.
  
  
  CONCLUSIONS
  The present study provides evidence that platelet numbers below 100,000 cells/mm(3) after day 100 and oral recurrent HHV-1 infection are independent negative prognostic variables in BMT patients' 24-month survival rates.
authors.affiliation: Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Av Antônio Carlos, 6627, Belo Horizonte-MG, Brazil 31270-901. rsgomez@net.em.com.br
authors.forename: R S
authors.initials: RS
authors.lastname: Gomez
authors.forename: M A
authors.initials: MA
authors.lastname: Carneiro
authors.forename: L N
authors.initials: LN
authors.lastname: Souza
authors.forename: J M
authors.initials: JM
authors.lastname: Victória
authors.forename: W M
authors.initials: WM
authors.lastname: de Azevedo
authors.forename: L
authors.initials: L
authors.lastname: De Marco
authors.forename: E
authors.initials: E
authors.lastname: Kalapothakis
mesh_terms: D000208:Acute Disease; D000212:Acyclovir / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000741:Anemia, Aplastic / Q000628:therapy; D000998:Antiviral Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002908:Chronic Disease; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology; D006801:Humans; D007938:Leukemia / Q000628:therapy; D016014:Linear Models; D008223:Lymphoma / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D010976:Platelet Count; D011379:Prognosis; D016016:Proportional Hazards Models; D012008:Recurrence; D012466:Salivary Gland Diseases / Q000209:etiology; D012737:Sex Factors; D013280:Stomatitis / Q000209:etiology; D013283:Stomatitis, Herpetic / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D015996:Survival Rate; D014019:Tissue Donors; D019172:Transplantation Conditioning
chemical_list: D000998:Antiviral Agents; D000212:Acyclovir